Fight Illicit Pill Presses Act
- Bill Number
- H.R. 5880
- Origin Chamber
- House
- Congress
- 119th Congress, Session 1
- Policy Area
- Crime and Law Enforcement
- Status
- Introduced
- Latest Action
- 2025-10-31: Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Last Updated
- 2026-07-07T14:50:35Z
AI-Generated Summary
Purpose
The "Fight Illicit Pill Presses Act" (H.R. 5880) aims to combat the illegal production of controlled substances, such as counterfeit pills containing fentanyl or other drugs, by requiring serial numbers on pill-making machines and their key parts. This makes it easier for authorities to track and regulate these devices, reducing their use in illicit drug manufacturing.
Key Provisions
- Expanded Definitions: Updates the Controlled Substances Act (CSA) to broaden the term "regulated person" to include anyone who manufactures, distributes, imports, exports, or brokers tableting machines (used to compress powder into tablets), encapsulating machines (used to fill capsules), or their "critical parts" (essential components like upper/lower punches and dies, which shape the pills).
- Serial Number Requirement: Regulated persons must affix a permanent serial number (engraved, cast, or otherwise fixed to a non-removable part) to these machines and critical parts during manufacturing, distribution, delivery, sale, import, or export, as directed by regulations from the Attorney General.
- Reporting Obligations: Transactions involving these machines or parts must be reported to the Attorney General, including the serial number, to maintain records for oversight.
- Regulations Timeline: The Attorney General must issue implementing regulations within 180 days of enactment, including guidance on adding serial numbers to machines or parts made before the law takes effect. Existing machines can comply via this guidance.
- Effective Date: Applies only to machines and parts handled after the regulations are issued.
- Prohibitions: Makes it illegal to:
- Remove, alter, or destroy a required serial number if there's reasonable belief it's needed.
- Transport, ship, possess, distribute, sell, import, or export these items knowing their serial number has been tampered with.
Significant Changes to Existing Law
- Broader Regulation: Previously, the CSA regulated listed chemicals and machines but lacked specific serial number mandates for tableting/encapsulating machines and their parts. This bill expands oversight to include brokers/traders in international deals and defines "critical parts" for the first time.
- Enhanced Reporting and Penalties: Adds serial number details to transaction reports and introduces new criminal prohibitions under CSA Section 403, treating tampering or possession of tampered items as unlawful acts (similar to existing rules for other controlled items).
- Retroactive Flexibility: Allows pre-enactment machines to be retrofitted with serial numbers per guidance, rather than banning them outright.
Potential Impacts
- On Government Agencies: Increases workload for the Department of Justice (via the Attorney General and likely the Drug Enforcement Administration) in issuing regulations, monitoring reports, and enforcing prohibitions, potentially improving investigations into illegal pill presses.
- On Citizens and Businesses: Legitimate manufacturers, distributors, and importers of pharmaceutical equipment face new compliance costs (e.g., engraving serial numbers), but this could reduce competition from illicit operators. Illicit drug producers may find it harder to anonymously acquire or modify machines, potentially decreasing illegal drug supply and overdose risks.
- On International Relations: Strengthens U.S. controls on exports/imports, which could affect trade with countries involved in machine production (e.g., China, a source of many pill presses), possibly leading to more international cooperation on drug trafficking.
Main Stakeholders Affected
- Regulated Persons: Manufacturers, distributors, sellers, importers, exporters, and brokers of tableting/encapsulating machines and critical parts, who must now track and report serial numbers.
- Law Enforcement and Regulators: The Attorney General, DEA, and related agencies, gaining tools to trace illicit equipment.
- Pharmaceutical and Medical Industries: Legitimate users of these machines (e.g., for legal drug production) may benefit from reduced illicit market interference but face added bureaucracy.
- Public Health and Consumers: Indirectly benefits those affected by the opioid crisis, as tracking could disrupt fake pill production; however, over-regulation might raise costs for legal pill manufacturing.
Notable Legal, Constitutional, or Political Implications
- Legal Implications: Strengthens the CSA's framework for preventing diversion of equipment to illegal uses, aligning with existing anti-trafficking laws. Violations could lead to civil or criminal penalties (fines, imprisonment) under the CSA, emphasizing "reasonable cause to believe" to avoid overly broad enforcement.
- Constitutional Implications: No apparent conflicts with core rights like due process or property; the requirements are regulatory (like vehicle VINs) and apply only to commercial activities. It respects interstate commerce by focusing on federal jurisdiction over controlled substances.
- Political Implications: Bipartisan sponsorship (from Republicans and Democrats) signals broad support for addressing the fentanyl crisis without partisan divides. Could set precedent for serializing other dual-use tools in drug enforcement, potentially influencing future anti-drug legislation.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Rep. Hageman, Harriet M. [R-WY-At Large]
Cosponsors (14)
Rep. Stansbury, Melanie A. [D-NM-1], Rep. Crenshaw, Dan [R-TX-2], Rep. Harder, Josh [D-CA-9], Rep. Fry, Russell [R-SC-7], Rep. Vindman, Eugene Simon [D-VA-7], Rep. Levin, Mike [D-CA-49], Rep. Tran, Derek [D-CA-45], Rep. Min, Dave [D-CA-47], Rep. Kaptur, Marcy [D-OH-9], Rep. Norcross, Donald [D-NJ-1], Rep. Thompson, Glenn [R-PA-15], Rep. Williams, Nikema [D-GA-5], Rep. Smith, Christopher H. [R-NJ-4], Rep. Lee, Susie [D-NV-3]
Recent Actions
- 2025-10-31: Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-10-31: Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-10-31: Introduced in House
- 2025-10-31: Introduced in House
Bill Versions
- Fight Illicit Pill Presses Act — issued 2025-10-31 — PDF (6 pages)